Galli, Mattia
 Distribuzione geografica
Continente #
NA - Nord America 1.632
AS - Asia 1.110
EU - Europa 1.007
SA - Sud America 262
AF - Africa 38
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 4
Totale 4.061
Nazione #
US - Stati Uniti d'America 1.593
SG - Singapore 581
SE - Svezia 260
CN - Cina 236
BR - Brasile 212
IT - Italia 183
DE - Germania 132
FR - Francia 101
IE - Irlanda 74
ID - Indonesia 49
IN - India 47
FI - Finlandia 46
PL - Polonia 46
VN - Vietnam 44
GB - Regno Unito 43
RU - Federazione Russa 32
HK - Hong Kong 27
JP - Giappone 24
UA - Ucraina 20
CA - Canada 19
IQ - Iraq 19
AR - Argentina 17
BD - Bangladesh 15
MX - Messico 14
NL - Olanda 14
AT - Austria 12
CZ - Repubblica Ceca 11
ET - Etiopia 11
CI - Costa d'Avorio 9
AU - Australia 8
IR - Iran 8
KR - Corea 8
TR - Turchia 8
VE - Venezuela 8
CO - Colombia 7
ZA - Sudafrica 7
BE - Belgio 6
AZ - Azerbaigian 5
EC - Ecuador 5
LT - Lituania 5
PK - Pakistan 5
AE - Emirati Arabi Uniti 4
CH - Svizzera 4
ES - Italia 4
IL - Israele 4
JO - Giordania 4
PY - Paraguay 4
QA - Qatar 4
UY - Uruguay 4
BG - Bulgaria 3
EU - Europa 3
MA - Marocco 3
PT - Portogallo 3
UZ - Uzbekistan 3
EG - Egitto 2
HN - Honduras 2
JM - Giamaica 2
KE - Kenya 2
KZ - Kazakistan 2
NP - Nepal 2
SA - Arabia Saudita 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BO - Bolivia 1
CL - Cile 1
CV - Capo Verde 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GR - Grecia 1
GY - Guiana 1
HU - Ungheria 1
KH - Cambogia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MM - Myanmar 1
MU - Mauritius 1
MY - Malesia 1
OM - Oman 1
PE - Perù 1
PH - Filippine 1
SI - Slovenia 1
SO - Somalia 1
SR - Suriname 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 4.061
Città #
Chandler 319
Singapore 270
Ashburn 149
New York 86
Beijing 85
Dublin 73
Los Angeles 48
Jakarta 47
Warsaw 42
Milan 37
San Mateo 37
Princeton 35
Boston 33
Wilmington 31
Helsinki 30
Rome 30
Bremen 28
Dallas 28
Marseille 26
Hong Kong 23
Moscow 23
The Dalles 23
Hefei 22
Munich 22
São Paulo 21
Ho Chi Minh City 20
Fairfield 18
Redwood City 18
Cattolica 17
Frankfurt am Main 17
Woodbridge 15
Tokyo 14
Augusta 13
Baghdad 13
Chicago 11
Hanoi 11
Seattle 11
Dearborn 10
Houston 10
Turku 10
Abidjan 9
Atlanta 9
Jacksonville 9
London 9
North Bergen 9
Paris 9
Pune 9
Denver 8
Düsseldorf 8
Falkenstein 8
Rio de Janeiro 8
Seoul 8
Brooklyn 7
Montreal 7
Nuremberg 7
Roubaix 7
Saint Louis 7
Stockholm 7
Vienna 7
Belo Horizonte 6
Brasília 6
Brussels 6
Groningen 6
Kent 6
Lappeenranta 6
Mumbai 6
Naples 6
Orem 6
Washington 6
Ann Arbor 5
Baku 5
Brno 5
Curitiba 5
Hyderabad 5
Leawood 5
Nanjing 5
Orangeburg 5
Phoenix 5
San Francisco 5
Santa Clara 5
Amman 4
Amsterdam 4
Andover 4
Asunción 4
Buffalo 4
Cambridge 4
Catania 4
Chennai 4
Dhaka 4
Doha 4
Florence 4
Guangzhou 4
Hollywood 4
Huntington 4
Johannesburg 4
Karlsruhe 4
Lauterbourg 4
Manchester 4
Mexico City 4
Osimo 4
Totale 2.123
Nome #
Ticagrelor and preconditioning in patients with stable coronary artery disease (TAPER-S): A randomized pilot clinical trial 218
Coronary Atherosclerotic Phenotype and Plaque Healing in Patients with Recurrent Acute Coronary Syndromes Compared with Patients with Long-term Clinical Stability: An in Vivo Optical Coherence Tomography Study 156
Impact of coronary stenting on top of medical therapy and of inclusion of periprocedural infarctions on hard composite endpoints in patients with chronic coronary syndromes: a meta-analysis of randomized controlled trials 152
ORal anticoagulants In fraGile patients with percutAneous endoscopic gastrostoMy and atrIal fibrillation: the (ORIGAMI) study 133
Sex-Related Differences in Dilated Cardiomyopathy with a Focus on Cardiac Dysfunction in Oncology 128
Coronary Atherosclerotic Phenotype and Plaque Healing in Patients with Recurrent Acute Coronary Syndromes Compared with Patients with Long-term Clinical Stability: An in Vivo Optical Coherence Tomography Study 121
Adenosine as adjunctive therapy in acute coronary syndrome: a meta-analysis of randomized controlled trials 118
ORal anticoagulants In fraGile patients with percutAneous endoscopic gastrostoMy and atrIal fibrillation: the (ORIGAMI) study 114
Role of perilipin 2 in microvascular obstruction in patients with ST-elevation myocardial infarction 114
Oral anticoagulants in fragile patients with percutaneous endoscopic gastrostomy and atrial fibrillation: the ORIGAMI pilot investigation 110
Intracoronary bolus of glycoprotein IIb/IIIa inhibitor as bridging or adjunctive strategy to oral P2Y12 inhibitor load in the modern setting of STEMI 108
Where Does Inflammation Fit? 103
Antithrombotic therapy in the early phase of non-ST-elevation acute coronary syndromes: A systematic review and meta-analysis 102
Experience of Remote Cardiac Care during Covid-19 Pandemic: the V-LAP™ device in advanced heart failure 101
Dual quantitative coronary angiography accurately quantifies intracoronary thrombotic burden in patients with acute coronary syndrome: Comparison with optical coherence tomography imaging 97
Role of perilipin 2 in microvascular obstruction in patients with ST-elevation myocardial infarction 97
Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials 97
A 3-Year Single Center Experience With Left Atrial Pressure Remote Monitoring: The Long and Winding Road 96
Device-based remote monitoring strategies for congestion-guided management of patients with heart failure: a systematic review and meta-analysis 96
Efficacy and safety of novel oral anticoagulants versus low molecular weight heparin in cancer patients with venous thromboembolism: A systematic review and meta-analysis 93
Genetic testing in patients undergoing percutaneous coronary intervention: rationale, evidence and practical recommendations 92
Neoatherosclerosis after drug-eluting stent implantation: A novel clinical and therapeutic challenge 89
Venoarterial extracorporeal membrane oxygenation (VA-ECMO) with vs without left ventricular unloading by Impella: a systematic review and meta-analysis 88
Intracranial haemorrhages vs. stent thromboses with direct oral anticoagulant plus single antiplatelet agent or triple antithrombotic therapy: a meta-analysis of randomized trials in atrial fibrillation and percutaneous coronary intervention/acute coronary syndrome patients 88
Comprehensive functional and anatomic assessment of myocardial bridging: Unlocking the Gordian Knot 87
Colchicine and risk of non-cardiovascular death in patients with coronary artery disease: A pooled analysis underling possible safety concerns 86
Pre-stenting residual thrombotic volume assessed by dual quantitative coronary angiography predicts microvascular obstruction in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention 80
Telemedicine, Artificial Intelligence and Humanisation of Clinical Pathways in Heart Failure Management: Back to the Future and Beyond 79
Gender-differences in antithrombotic therapy across the spectrum of ischemic heart disease: Time to tackle the Yentl syndrome? 78
Efficacy and safety of dual pathway inhibition in patients with cardiovascular disease: a systematic review and Meta-analysis 78
How deep is your lesion? Extreme guideliner V3 intubation through RIMA graft to treat a distal left anterior descending artery stenosis 77
Response - Letter to the editor: Colchicine and risk of non-cardiovascular death in patients with coronary artery disease: A pooled analysis underlying possible safety concerns 77
Sustained safe and effective anticoagulation using Edoxaban via percutaneous endoscopic gastrostomy 75
Revascularization strategies versus optimal medical therapy in chronic coronary syndrome: A network meta-analysis 75
Dropping aspirin in patients with atrial fibrillation undergoing percutaneous coronary intervention: A jump with a weak parachute? 74
Early anticoagulation in the current management of NSTE-ACS: Evidence, guidelines, practice and perspectives 74
Double or triple antithrombotic therapy for patients with atrial fibrillation undergoing percutaneous coronary intervention: Not a matter of faith 74
Very short vs. long dual antiplatelet therapy after second generation drug-eluting stents in 35 785 patients undergoing percutaneous coronary interventions: a meta-analysis of randomized controlled trials 72
Do We Need to Define Therapeutic Ranges for Edoxaban Plasma Concentration? 69
Do We Need to Define Therapeutic Ranges for Edoxaban Plasma Concentration? 65
Randomised trials and meta-analyses of double vs triple antithrombotic therapy for atrial fibrillation-ACS/PCI: A critical appraisal 57
Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs 50
Stent Thrombosis With Dual Antithrombotic Therapy in Atrial Fibrillation–ACS/PCI Trials 38
Aspirin in primary prevention of cardiovascular disease in the elderly 36
Totale 4.112
Categoria #
all - tutte 20.532
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.532


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021136 0 0 0 0 0 46 22 9 6 15 31 7
2021/2022393 25 11 0 31 12 7 6 45 20 22 152 62
2022/2023921 102 108 65 143 47 124 56 80 136 10 29 21
2023/2024476 20 112 17 55 23 71 45 17 8 20 44 44
2024/2025816 19 14 68 44 65 46 28 39 113 98 165 117
2025/20261.189 349 34 96 233 404 73 0 0 0 0 0 0
Totale 4.112